From the Journals

Resistant hypertension hits SLE patients hard


 

FROM ARTHRITIS CARE & RESEARCH

Patients with systemic lupus erythematosus (SLE) were 72% more likely to have resistant hypertension than were control patients at a tertiary care center.

wildpixel/Thinkstock

A patient with resistant hypertension either has blood pressure remaining above 140/90 mm Hg while taking three antihypertensive medications or requires the use of four or more antihypertensives to attain blood pressure control. Resistant hypertension, which was more likely to occur among blacks and patients with lower renal function, hypercholesterolemia, and increased inflammatory markers, increased the risk of death nearly threefold (hazard ratio, 2.91; P = .0005) when compared with those who didn’t have this condition.


The results of this analysis were published March 15 in Arthritis Care & Research (doi: 10.1002/acr.23880). We covered this study at the 2018 annual meeting of the American College of Rheumatology in Chicago before it was published in the journal. Read our previous story at the link above.

Recommended Reading

Heart disease in GPA exacts high toll in year 2 and beyond
MDedge Cardiology
Low vitamin D linked with DVT in lupus patients
MDedge Cardiology
Prolonged antimalarial therapy linked to elevated cardiac biomarkers, cardiomyopathy
MDedge Cardiology
Two red flags spell trouble ahead in spontaneous coronary artery dissection
MDedge Cardiology
Guideline-recommended tests’ prognostic ability affirmed in prostanoid-treated PAH
MDedge Cardiology
Two distinct subtypes of SLE-linked pulmonary arterial hypertension described
MDedge Cardiology
Antimalarial-induced cardiomyopathy in lupus may be underrecognized
MDedge Cardiology
Antiphospholipid antibodies are surprisingly common in first-MI patients
MDedge Cardiology
Fever, intestinal symptoms may delay diagnosis of Kawasaki disease in children
MDedge Cardiology
High incidence of treatment-resistant hypertension in SLE comes with high mortality
MDedge Cardiology